Bonaire, Sint Eustatius and Saba vs Puerto Rico: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bonaire, Sint Eustatius and Saba
0.2%
in 2024
Puerto Rico
0.2%
in 2024
Bonaire, Sint Eustatius and Saba rank
98th
Puerto Rico rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bonaire, Sint Eustatius and Saba
- Puerto Rico
How they compare
Bonaire, Sint Eustatius and Saba currently reports 0.2% against 0.2% in Puerto Rico, a difference of 0.0%.
Across all 10 years both countries report, Puerto Rico has been ahead every year.
Bonaire, Sint Eustatius and Saba ranks 98th and Puerto Rico ranks 98th of 246 countries.
Head to head by decade
| Decade | Bonaire, Sint Eustatius and Saba | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bonaire, Sint Eustatius and Saba or Puerto Rico?
- Bonaire, Sint Eustatius and Saba, at 0.2% against 0.2% in Puerto Rico as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bonaire, Sint Eustatius and Saba and Puerto Rico?
- 0.0%, with Bonaire, Sint Eustatius and Saba ahead.
- How many years of comparable data are there for Bonaire, Sint Eustatius and Saba and Puerto Rico?
- 10 years are reported by both, from 2015 to 2024.
- How do Bonaire, Sint Eustatius and Saba and Puerto Rico rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bonaire, Sint Eustatius and Saba ranks 98th and Puerto Rico ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.